Literature DB >> 18056750

In vitro bioassays for androgens and their diagnostic applications.

P Roy1, M Alevizaki, I Huhtaniemi.   

Abstract

Androgen levels are measured in today's clinical practice almost exclusively by immunoassays. The androgen that is most frequently determined is testosterone (T), but sometimes also the levels of other testicular, ovarian and adrenal androgens such as 5alpha-dihydrotestosterone, androstenedione, dehydroepiandrosterone and its sulphate may be determined. In many instances, especially when androgen levels are low (as in women and children), the quality of the immunomeasurements is insufficient and the correlation between hormone levels and clinical symptoms is poor. One alternative to improve the clinical relevance of androgen measurements is provided by the recently developed in vitro bioassays of total androgen bioactivity in serum. These assays are not yet ready for routine laboratory diagnostics, but they provide a useful tool for clinical research in disturbances of androgen production. Another application of these assays is the screening for androgenic and antiandrogenic activity in chemical compounds, environmental samples and when suspecting androgen abuse. The purpose of this article is to introduce the current problems of androgen measurement by immunoassays, to describe the novel in vitro bioassay techniques and to review the current information on their application in clinical research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056750     DOI: 10.1093/humupd/dmm038

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  8 in total

Review 1.  Cell-based assays for screening androgen receptor ligands.

Authors:  Carmela Campana; Vincenzo Pezzi; William E Rainey
Journal:  Semin Reprod Med       Date:  2015-06-02       Impact factor: 1.303

Review 2.  The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.

Authors:  Amy B Cadwallader; Carol S Lim; Douglas E Rollins; Francesco Botrè
Journal:  J Anal Toxicol       Date:  2011-11       Impact factor: 3.367

3.  Development of a novel cell based androgen screening model.

Authors:  Carmela Campana; Juilee Rege; Adina F Turcu; Vincenzo Pezzi; Celso E Gomez-Sanchez; Diane M Robins; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-11-12       Impact factor: 4.292

4.  The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women.

Authors:  T G Valderhaug; J K Hertel; N Nordstrand; P O Dale; D Hofsø; J Hjelmesæth
Journal:  Diabetol Metab Syndr       Date:  2015-05-21       Impact factor: 3.320

Review 5.  In vitro reporter assays for screening of chemicals that disrupt androgen signaling.

Authors:  Gargi Bagchi Bhattacharjee; S M Paul Khurana
Journal:  J Toxicol       Date:  2014-11-09

6.  Polycystic Ovary Syndrome: Novel and Hub lncRNAs in the Insulin Resistance-Associated lncRNA-mRNA Network.

Authors:  Jun Zhao; Jiayu Huang; Xueying Geng; Weiwei Chu; Shang Li; Zi-Jiang Chen; Yanzhi Du
Journal:  Front Genet       Date:  2019-08-22       Impact factor: 4.599

7.  Free testosterone and cardiometabolic parameters in men: comparison of algorithms.

Authors:  Stine A Holmboe; Ravi Jasuja; Brian Lawney; Lærke Priskorn; Niels Joergensen; Allan Linneberg; Tina Kold Jensen; Niels Erik Skakkebæk; Anders Juul; Anna-Maria Andersson
Journal:  Endocr Connect       Date:  2021-02       Impact factor: 3.335

8.  A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals.

Authors:  Adam T Szafran; Michael J Bolt; Caroline E Obkirchner; Maureen G Mancini; Christine Helsen; Frank Claessens; Fabio Stossi; Michael A Mancini
Journal:  SLAS Discov       Date:  2020-05-11       Impact factor: 3.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.